RIPK1 Biallelic Activating Variants lead to Autoinflammatory Disease Driven by T cell Death
Jialin Dai(Sir Run Run Shaw Hospital), Qing Zhou(Zhejiang University)
Cited by 3
Related Papers
Identification of an IL-1 receptor mutation driving autoinflammation directs IL-1-targeted drug design
|Immunity|2023|77
A gain-of-function variation in PLCG1 causes a new immune dysregulation disease
|Journal of Allergy and Clinical Immunology|2023|34